drugset / Trial / NCT02526394

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

NCT02526394

Phase 4 Completed 400 enrolled Public Health England
RandomizedParallel-groupOpen-labelTreatment

Summary

The trial includes groups receiving various combinations of meningitis C and pertussis containing vaccines, to be administered concomitantly in adolescents due their school leaving booster vaccinations (as per UK routine immunisation schedule at 13-17 years of age). Immunogenicity and reactogenicity will be assessed.

Timeline

Start
2013-09
Primary completion
2017-03-31
Completion
2017-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Boostrix Vaccine Other
Comparator Meningitec Vaccine Other
Comparator Menitorix Vaccine Other
Comparator Menveo Vaccine Other
Comparator NeisVac-C Vaccine Other
Comparator REPEVAX Vaccine Other